anticoagulation
Showing 26 - 50 of 2,563
Respiratory Failure Trial in Beijing (Argatroban, unfractionated heparin)
Recruiting
- Respiratory Failure
- Argatroban
- unfractionated heparin
-
Beijing, Beijing, ChinaBing Sun
Nov 8, 2022
Acute Hypoxemic Respiratory Failure, Anticoagulant-induced Bleeding, Thromboembolism Trial in Nashville (Low intensity
Recruiting
- Acute Hypoxemic Respiratory Failure
- +2 more
- Low intensity anticoagulation
- Moderate Intensity Anticoagulation
-
Nashville, TennesseeVanderbilt University Medical Center
May 15, 2022
Atrial Fibrillation, Atrial Flutter, Adherence, Medication Trial in Worcester, Ann Arbor (Storytelling Intervention)
Not yet recruiting
- Atrial Fibrillation
- +6 more
- Storytelling Intervention
-
Worcester, Massachusetts
- +1 more
Aug 11, 2023
Hereditary Hemorrhagic Telangiectasia, Rendu Osler Disease Trial in Clermont-Ferrand (monitoring the use of anticoagulant and/or
Not yet recruiting
- Hereditary Hemorrhagic Telangiectasia
- Rendu Osler Disease
- monitoring the use of anticoagulant and/or antiplatelet therapy in patients with osler rendering disease
-
Clermont-Ferrand, FranceCHU clermont-ferrand
Nov 29, 2022
Acute Kidney Injury Trial in São Paulo (Effects of increased blood flow during regional anticoagulation with 4% trisodium
Recruiting
- Acute Kidney Injury
- Effects of increased blood flow during regional anticoagulation with 4% trisodium citrate in patients undergoing continuous venovenous hemodiafiltration
-
São Paulo, BrazilHospital Israelite Albert Einstein
Apr 4, 2023
Upper Gastrointestinal Bleeding, Peptic Ulcer Hemorrhage, Anticoagulant-induced Bleeding Trial in Ann Arbor (Clinician
Completed
- Upper Gastrointestinal Bleeding
- +2 more
- Clinician Notification with Nurse Facilitation (CNNF)
- Wait list control
-
Ann Arbor, MichiganUniversity of Michigan
Jan 4, 2023
STEMI - ST Elevation Myocardial Infarction Trial in Beijing (Bivalirudin, Enoxaparin, Unfractionated heparin)
Active, not recruiting
- STEMI - ST Elevation Myocardial Infarction
- Bivalirudin
- +5 more
-
Beijing, ChinaBeijing Anzhen Hospital, Capital Medical University
Apr 10, 2022
Cirrhosis, Portal Vein Thrombosis, Esophageal and Gastric Varices Trial in Jinan (nadroparin calcium-warfarin sequential
Completed
- Cirrhosis
- +3 more
- nadroparin calcium-warfarin sequential anticoagulation
-
Jinan, Shandong, ChinaDepartment of Gastroenterology,Qilu Hospital,Shandong University
Jul 3, 2022
Extracorporeal Membrane Oxygenation Complication Trial in Sydney (Unfractionated heparin, Bivalirudin)
Not yet recruiting
- Extracorporeal Membrane Oxygenation Complication
- Unfractionated heparin
- Bivalirudin
-
Sydney, New South Wales, AustraliaRoyal Prince Alfred Hospital
Jul 26, 2023
No Cases of Delayed Intracranial Hemorrhage Among Mild Traumatic
Completed
- Traumatic Intracranial Hemorrhage
- Traumatic Brain Injury
- no intervention, only observational retrospective study
-
Sundsvall, SwedenSundsvall Hospital
Nov 1, 2022
Venous Thrombosis, Tumors, Anticoagulant Trial in Kyoto (12-month Edoxaban, 3-month Edoxaban)
Active, not recruiting
- Venous Thrombosis
- +2 more
- 12-month Edoxaban
- 3-month Edoxaban
-
Kyoto, JapanDepartment of Cardiovascular Medicine, Kyoto University Graduate
Aug 16, 2022
Covid19 Trial in Germany (Anticoagulation Agents (Edoxaban and/or high dose LMWH), Low dose Low molecular weight heparin or
Recruiting
- Covid19
- Anticoagulation Agents (Edoxaban and/or high dose LMWH)
- Low dose Low molecular weight heparin or Placebo
-
Aachen, Germany
- +9 more
May 16, 2022
Hemodialysis Complication, Bleeding Trial in France (anticoagulation of the dialysis circuit)
Completed
- Hemodialysis Complication
- Bleeding
- anticoagulation of the dialysis circuit
-
Bordeaux, France
- +4 more
Mar 15, 2022
Prolonged Anticoagulation, Venous Thromboembolic Disease, Autoimmune Hemolytic Anemia Trial in Dijon (treatment "intervention",
Recruiting
- Prolonged Anticoagulation
- +2 more
- treatment "intervention"
- +2 more
-
Dijon, FranceChu Dijon Bourgogne
Jul 4, 2022
Anticoagulation, Coronary Endarterectomy Trial (Warfarin, DAPT, CE+CABG)
Not yet recruiting
- Anticoagulation
- Coronary Endarterectomy
- Warfarin
- +2 more
- (no location specified)
Mar 26, 2023
Atrial Fibrillation (AF) Trial in Johns Creek, Charlotte, Lenoir (Abelacimab, Placebo)
Recruiting
- Atrial Fibrillation (AF)
- Abelacimab
- Placebo
-
Johns Creek, Georgia
- +2 more
Jan 25, 2023
Oral Anticoagulation Drugs and How Well These Drugs Work in Real
Active, not recruiting
- Atrial Fibrillation
- Rivaroxaban (Xarelto)
- +3 more
-
Multiple Locations, SwedenMany locations
Jan 20, 2023
Apheresis, Anticoagulation Trial in Ljubljana (unfractionated heparin, Sodium Citrate)
Recruiting
- Apheresis
- Anticoagulation
- unfractionated heparin
- Sodium Citrate
-
Ljubljana, SloveniaUniversity Medical Center Ljubljana
Jan 21, 2022
Pulmonary Embolism, Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Tucson (Catheter directed
Recruiting
- Pulmonary Embolism
- +2 more
- Catheter directed therapy
- Systemic anticoagulation
-
Tucson, ArizonaBanner University Medical Center
Sep 21, 2022
Coronary Artery Disease, Bleeding, Direct Acting Anticoagulant Adverse Reaction Trial in Italy, Spain (Direct-acting oral
Recruiting
- Coronary Artery Disease
- +2 more
- Direct-acting oral anticoagulation
-
Rozzano, Milan, Italy
- +3 more
Mar 22, 2022
Cancer-associated Thrombosis, Thrombocytopenia Trial (Enoxaparin, Dalteparin, Tinzaparin)
Not yet recruiting
- Cancer-associated Thrombosis
- Thrombocytopenia
- Enoxaparin
- +2 more
- (no location specified)
Apr 19, 2022
Subdural Hematoma, Atrial Fibrillation Trial in Toronto (Direct Acting Oral Anticoagulant starting at Day 30, Direct Acting Oral
Not yet recruiting
- Subdural Hematoma
- Atrial Fibrillation
- Direct Acting Oral Anticoagulant starting at Day 30
- Direct Acting Oral Anticoagulant starting at Day 90
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Jul 26, 2022
Renal Replacement Therapy Trial in Guangzhou (HSK36273, Heparin sodium)
Not yet recruiting
- Renal Replacement Therapy
- HSK36273
- Heparin sodium
-
Guangzhou, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Nov 1, 2022